Research topics: Drug delivery and targeting, controlled release dosage forms (nanoparticles, liposomes) Targeting of biopharmaceuticals using on the organ/tissue.

Slides:

Advertisements

Similar presentations

Howard E. Gendelman, MD Larson Professor of Medicine and Infectious Diseases Chairman, Department of Pharmacology and Experimental Neuroscience Director,

Advertisements

The Drug Discovery Process

Antigen Presentation K.J. Goodrum Department of Biomedical Sciences Ohio University 2005.

Ramana S. Uppoor, M.Pharm., Ph.D., R.Ph.

DRUG-RECEPTOR INTERACTIONS

1 Xavier University of Louisiana College of Pharmacy Curriculum Map – NAPLEX Competencies Map by Course.

Applications of Nanoparticles for Delivery of Therapeutic Agents Frank Jeyson Hernández Topics of Nanobiotechnology 30 June, 2004.

Lecture 3 clinical immunology Antigen Presenting Cells

Nanotechnology in Drug Discovery- Development and Delivery

Xavier University of Louisiana College of Pharmacy Curriculum Map – Program Outcomes Map by Course.

Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.

OPTIMISING MEDICINES DEVELOPMENT

+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.

Transdermal Drug Delivery – Assessment of in vitro skin permeation Shashank Jain.

Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 1 Improvement in Dose Selection: FDA Perspective IDSA/ISAP/FDA Workshop.

Host Defense Clinical and Experimental Immunologic Assays II Domenick Kennedy Dept. Microbiology and Immunology

Curcumin, the constituent of Curcuma longa, is considered a very promising anticancer agent due to its potent and pleiotropic antineoplastic activity and.

Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 In Vitro/Animal Models to Support Dosage Selection: FDA Perspective.

Concepts and Applications of Pharmacokinetics

Rational Dosing: The Use of Plasma Concentrations vs. Tissue Concentrations Hartmut Derendorf, PhD University of Florida.

Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: -relationship.

1 Xavier University of Louisiana College of Pharmacy Curriculum Map – NAPLEX Competencies Map by Competency.

Bioequivalence of Locally Acting Gastrointestinal Drugs: An Overview

CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.

Bioavailability Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.

Modular Nanodevices for Creation of Smart Adaptable Vaccine Delivery Vehicles Tarek M. Fahmy Dept. of Biomedical Engineering, Yale University Several key.

PHARMACEUTICS- IV (PHT 414 ) Dr. Mohammad Khalid Anwer SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L111/16/2016.

INTRODUCTION CLINICAL PHARMACOKINETICS

Introduction of Biopharmaceutics and Pharmacokinetics

1 Pharmacokinetics: Introduction Dr Mohammad Issa.

School of Pharmacy - The University of Auckland Formulation and Drug Delivery Research Theme School of Pharmacy, the University of Auckland, Auckland,

Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy, University of Andalas.

Modern aspects of drugs production. Differences.

Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.

1 The Role of Exposure-Response Evaluation in Drug Development and Regulatory Decisions Case Study: Rosuvastatin Hae-Young Ahn, Ph.D. Office of Clinical.

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Principles of Drug Action.

The General Concepts of Pharmacokinetics and Pharmacodynamics

Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 Current Status of Dose Selection in Antimicrobial Drug Development.

1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.

Definitions and Concepts

BIOAVAILABILITY AND METHODS OF ENHANCING BIOAVAILABILITY 1 Presented by SHAHEEN BEGUM Hallticket No:10S91R0035 UNDER THE GUIDANCE OF Associate Professor.

APPLICATION OF ELECTROSPINNING Drug Delivery. Introduction ■During recent decades, nanoscaled drug delivery systems (DDSs) have gained much attention.

Page 1 Protein Labeling — Creative BioMart. Page 2 Our custom protein labeling & conjugation service provides personalized solutions designed to supply.

Brain Barrier Research Center:

Intracellular Pathogens Extracellular Pathogens

OMICS Journals are welcoming Submissions

Understanding the Basics of Pharmacology

Darts Sciences Darts Target Identification.

Liposome product Liposome product in Creative Biostructure.

Drug Affinity Responsive Target Stability (DARTS).

Non-PEGylated Liposome Production Non-PEGylated Liposome Production —Creative Biostructure.

Hanneke van der Lee, MD, PhD

From Bench to Clinical Applications: Money Talks

Biopharmaceutics Dr Mohammad Issa Saleh.

Insight into the Pharmaceutical Industry

The three primary ADC components that determine which cells are targeted (antibody), how the drug is released (linker/trigger), and the mechanism of action.

Drug Design and Drug Discovery

My typical day as a scientist in pre-clinical at AZ/MedI

Scientific Drivers Technology in Development Issues Viral vectors

Chapter 1 Introduction of Pharmacology [,fɑ:mə'kɔlədʒi] 药理学

Publishers of Quality Research

Introduction to Pharmacology

By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology

Pharmacokinetics: Drug Absorption

Selvadurai Muralidharan, Kalaimani Jaya Raja Kumar

Introduction to Pharmacogenetics

Introduction to Pharmacology

Considerations for Successful Biopharmaceutical Product Development: Discovery to Proof of Concept -A Panel Discussion Stanley C. McDermott, PharmD, MS,

Presentation transcript:

Research topics: Drug delivery and targeting, controlled release dosage forms (nanoparticles, liposomes) Targeting of biopharmaceuticals using on the organ/tissue and intracellular levels Preclinical and clinical pharmacokinetics and pharmacodynamics, PK/PD modeling Seeks cooperation in the following areas: development of new drugs, more efficient use of the existing drugs, investigating the mechanisms of action of drug leads Selected recent publications: Sneh-Edri H, Likhtenshtein D, Stepensky D. Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro. Mol Pharmaceutics 2011; 8(4): Dakwar G, Hammad IA, Popov M, Linder C, Grinberg S, Heldman E, Stepensky D. Delivery of proteins to the brain by bolaamphiphilic nano-sized vesicles. J Control Release 2012; 160(2): Stepensky D. Local vs. systemic anti-TNF-alpha effects of adalimumab in rheumatoid arthritis: pharmacokinetic modeling analysis of interaction between a soluble target and a drug. Clin Pharmacokinet 2012; 51(7): David Stepensky Department of Clinical Biochemistry and Pharmacology and School of Pharmacy Faculty of Health Sciences M6 bldg., room

intracellular targeting of nanoparticles Brain-targeted drug delivery using nanovesicles

PK-PD modeling analysis of adalimumab disposition and location of site of action Drug Drug (antibody) Target (TNF-α) Target k syn k degr TD k el k on k off Drug-Target complex Disposition of adalimumab and TNF  and their interaction. Location of site of action of adalimumab. Optimal dosage form and dose of adalimumab. Population PK-PD and dose optimization in the individual subjects.